Vitanova Biomedical
Kerrville, US · Texas corporation
Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.
Founders & leadership
MG
Matthew GdovinFounder & Chief Science Officer
MJ
Matthew J GdovinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$745K disclosed across 2 of 3 rounds · 2018–2026
▶$8MofferedMay 2026 · BiotechnologyRule 506(b)
▶$8MofferedMay 2026 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew J GdovinExecutive Officer
- Offering amount
- $8M
- Minimum investment
- $25K
- Proceeds to insiders
- $110K
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b, 3C, 3C.1
▶$325KraisedJun 2021 · 5 investors · BiotechnologyRule 506(b)
▶$325KraisedJun 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MATTHEW GDOVINExecutive Officer, Director
- GREG ESPENHOVERExecutive Officer, Director
- THOMAS C/O VITANOVA BIOMEDICAL, INC. ROBERTSExecutive Officer, Director
- Offering amount
- $6.5M
- Amount sold
- $325K
- Minimum investment
- $25K
- Sales commissions
- $150K
- Proceeds to insiders
- $600K
- Placement agents
- THE OCMX
- First sale
- Aug 2019
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$420KraisedAug 2019 · 8 investors · BiotechnologyRule 506(b)
▶$420KraisedAug 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- GREG ESPENHOVERExecutive Officer, Director
- THOMAS ROBERTSExecutive Officer, Director
- MATTHEW GDOVINExecutive Officer, Director
- Offering amount
- $420K
- Amount sold
- $420K
- Minimum investment
- $5K
- Proceeds to insiders
- $220K
- First sale
- Feb 2018
- Incorporated
- Corporation, Texas, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapBioworld5 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Synnovation Therapeutics5 shared keywordsA drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
Minerva Biotechnologies4 shared keywordsMinerva Biotechnologies develops cancer and stem cell therapeutics, including cancer immunotherapies aimed at solid tumors and preventing cancer metastasis. The company also works on patient-derived stem cells for regenerative medicine.
Northwest Biotherapeutics4 shared keywordsNorthwest Biotherapeutics is a clinical-stage biotechnology company developing personalized cancer vaccines, marketed under the DCVax platform, that use activated dendritic cells to treat a range of solid tumor cancers. Its product lines include DCVax-L, DCVax-Direct, and DCVax-Prostate.
Vianovatx4 shared keywordsVia Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.
Companies competing with Vitanova Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Vitanova Biomedical do?
- Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.
- Who founded Vitanova Biomedical?
- Vitanova Biomedical was founded by Matthew Gdovin.
- How much funding has Vitanova Biomedical raised?
- Vitanova Biomedical has disclosed $745K raised across 2 of its 3 known rounds.
- Where is Vitanova Biomedical headquartered?
- Vitanova Biomedical is headquartered in Kerrville, US.